163 related articles for article (PubMed ID: 28468967)
1. High SYK Expression Drives Constitutive Activation of CD21
Keller B; Stumpf I; Strohmeier V; Usadel S; Verhoeyen E; Eibel H; Warnatz K
J Immunol; 2017 Jun; 198(11):4285-4292. PubMed ID: 28468967
[TBL] [Abstract][Full Text] [Related]
2. Disturbed canonical nuclear factor of κ light chain signaling in B cells of patients with common variable immunodeficiency.
Keller B; Cseresnyes Z; Stumpf I; Wehr C; Fliegauf M; Bulashevska A; Usadel S; Grimbacher B; Rizzi M; Eibel H; Niesner R; Warnatz K
J Allergy Clin Immunol; 2017 Jan; 139(1):220-231.e8. PubMed ID: 27461466
[TBL] [Abstract][Full Text] [Related]
3. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
[TBL] [Abstract][Full Text] [Related]
4. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav.
Lottin-Divoux S; Jean D; Le Romancer M; Frade R
Cell Signal; 2006 Aug; 18(8):1219-25. PubMed ID: 16289966
[TBL] [Abstract][Full Text] [Related]
5. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
6. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts.
Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D
J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency.
Visentini M; Marrapodi R; Conti V; Mitrevski M; Camponeschi A; Lazzeri C; Carbonari M; Catizone A; Quinti I; Fiorilli M
J Allergy Clin Immunol; 2014 Aug; 134(2):401-10. PubMed ID: 24792875
[TBL] [Abstract][Full Text] [Related]
8. Mercury alters endogenous phosphorylation profiles of SYK in murine B cells.
Caruso JA; Carruthers N; Shin N; Gill R; Stemmer PM; Rosenspire A
BMC Immunol; 2017 Jul; 18(1):37. PubMed ID: 28716125
[TBL] [Abstract][Full Text] [Related]
9. Syk mediates BCR- and CD40-signaling integration during B cell activation.
Ying H; Li Z; Yang L; Zhang J
Immunobiology; 2011 May; 216(5):566-70. PubMed ID: 21074890
[TBL] [Abstract][Full Text] [Related]
10. Naive- and Memory-like CD21
Freudenhammer M; Voll RE; Binder SC; Keller B; Warnatz K
J Immunol; 2020 Oct; 205(8):2016-2025. PubMed ID: 32907998
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
14. Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases.
Weißenberg SY; Szelinski F; Schrezenmeier E; Stefanski AL; Wiedemann A; Rincon-Arevalo H; Welle A; Jungmann A; Nordström K; Walter J; Imgenberg-Kreuz J; Nordmark G; Rönnblom L; Bachali P; Catalina MD; Grammer AC; Lipsky PE; Lino AC; Dörner T
Front Immunol; 2019; 10():2136. PubMed ID: 31616406
[TBL] [Abstract][Full Text] [Related]
15. CD72-mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase.
Venkataraman C; Lu PJ; Buhl AM; Chen CS; Cambier JC; Bondada S
Eur J Immunol; 1998 Oct; 28(10):3003-16. PubMed ID: 9808169
[TBL] [Abstract][Full Text] [Related]
16. Bruton's Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints.
Hsu J; Gu Y; Tan SL; Narula S; DeMartino JA; Liao C
Immunol Lett; 2013 Feb; 150(1-2):97-104. PubMed ID: 23266841
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
[TBL] [Abstract][Full Text] [Related]
18. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells.
Pao LI; Cambier JC
J Immunol; 1997 Mar; 158(6):2663-9. PubMed ID: 9058799
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation.
Carsetti L; Laurenti L; Gobessi S; Longo PG; Leone G; Efremov DG
Cell Signal; 2009 Jul; 21(7):1187-94. PubMed ID: 19296913
[TBL] [Abstract][Full Text] [Related]
20. The expansion of human T-bet
Keller B; Strohmeier V; Harder I; Unger S; Payne KJ; Andrieux G; Boerries M; Felixberger PT; Landry JJM; Nieters A; Rensing-Ehl A; Salzer U; Frede N; Usadel S; Elling R; Speckmann C; Hainmann I; Ralph E; Gilmour K; Wentink MWJ; van der Burg M; Kuehn HS; Rosenzweig SD; Kölsch U; von Bernuth H; Kaiser-Labusch P; Gothe F; Hambleton S; Vlagea AD; Garcia Garcia A; Alsina L; Markelj G; Avcin T; Vasconcelos J; Guedes M; Ding JY; Ku CL; Shadur B; Avery DT; Venhoff N; Thiel J; Becker H; Erazo-Borrás L; Trujillo-Vargas CM; Franco JL; Fieschi C; Okada S; Gray PE; Uzel G; Casanova JL; Fliegauf M; Grimbacher B; Eibel H; Ehl S; Voll RE; Rizzi M; Stepensky P; Benes V; Ma CS; Bossen C; Tangye SG; Warnatz K
Sci Immunol; 2021 Oct; 6(64):eabh0891. PubMed ID: 34623902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
